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Abstract
Intestinal epithelial cells (IECs) provide a physical and immunological barrier against enteric
microbial flora. Toll-like receptors (TLRs), through interactions with conserved microbial
patterns, activate inflammatory gene expression in cells of the innate immune system. Previous
studies of the expression and function of TLRs in IECs have reported varying results. Therefore,
TLR expression was characterized in human and murine intestinal sections, and TLR function was
tested in an IEC line. TLR1, TLR2, and TLR4 are coexpressed on a subpopulation of human and
murine IECs that reside predominantly in the intestinal crypt and belong to the enteroendocrine
lineage. An enteroendocrine cell (EEC) line demonstrated a similar expression pattern of TLRs as
primary cells. The murine EEC line STC-1 was activated with specific TLR ligands: LPS or
synthetic bacterial lipoprotein. In STC-1 cells stimulated with bacterial ligands, NF-κB and
MAPK activation was demonstrated. Furthermore, the expression of TNF and macrophage
inhibitory protein-2 were induced. Additionally, bacterial ligands induced the expression of the
anti-inflammatory gene transforming growth factor-β. LPS triggered a calcium flux in STC-1
cells, resulting in a rapid increase in CCK secretion. Finally, conditioned media from STC-1 cells
inhibited the production of nitric oxide and IL-12 p40 by activated macrophages. In conclusion,
human and murine IECs that express TLRs belong to the enteroendocrine lineage. Using a murine
EEC model, a broad range of functional effects of TLR activation was demonstrated. This study
suggests a potential role for EECs in innate immune responses.
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HOST DEFENSE against microorganisms relies on both innate and adaptive immune responses. The
molecular components of innate immunity are evolutionarily conserved over an
extraordinary spectrum of life forms, from plants to mammals (28). Receptors of the innate
immune system are known as pattern recognition receptors (PRRs). PRRs identify and bind
to a conserved set of molecular structures expressed on diverse organisms. Hence, the innate
immune system has evolved receptors that can recognize essential and unique features of
microbial structure, such as LPS, bacterial lipoproteins (BLPs), mannans, and double-
stranded RNA (18, 27). One evolution-arily conserved family of PRRs, the Toll-like
receptors (TLRs), is a particularly important component of the innate immune response.
TLRs are transmembrane molecules composed of multiple extracellular leucine-rich repeats,
a single transmembrane domain, and an intracellular signaling domain. TLRs activate the
transcription factor NF-κB and inflammatory gene expression through an evolutionarily
conserved signal transduction pathway (28).
Intestinal epithelial cells (IECs) serve as a physical and immunological interface with
microbial flora that colonize and traverse the intestinal lumen. Among the immunological
functions ascribed to IECs are cytokine production upon intracellular infection with
pathogenic intestinal bacteria (9, 20, 21). This implicates IECs as important participants in
innate immune responses of the intestinal mucosa. Therefore, it is of great interest and
potential clinical relevance to determine the role of TLRs in IEC innate immune responses.
In human tissue sections, TLR2 and TLR4 were “barely detectable” on IECs from human
tissue sections (5). Upregulation of TLR4 in the inflammatory bowel diseases (IBDs) of
Crohn's disease (CD) and ulcerative colitis (UC) and downregulation of TLR3 in CD but not
UC was also described (5). Conversely, another group (14) reported that TLR2 and TLR4
were not expressed in IECs from the normal or inflamed human intestine and that, in fact,
TLR expression was confined to lamina propria macrophages from inflamed tissue sections.
Likewise, there are controversial reports about TLR4 function in human IEC lines, with
some reporting LPS responsiveness (6, 35) and others suggesting LPS resistance due to the
absence of TLR4 and/or a coreceptor (2, 32, 49) or induction of inhibitory signaling
molecules (35). Furthermore, a functional role for TLR5 has been suggested, and one report
has described hyporesponsiveness of TLR2 in IEC lines (6, 13, 30). Therefore, the nature of
intestinal epithelial TLR expression and function remains incompletely understood.
In this study, abundant expression of multiple TLRs was demonstrated in human and murine
IECs that reside primarily in the crypt and belong to the enteroendocrine lineage. Possible
functional consequences of TLR expression and activation were explored using an
enteroendocrine cell (EEC) line. This study suggests a potential role for EECs in innate
immune responses and shows that EEC-bacterial interactions help maintain mucosal
immune homeostasis.
MATERIALS AND METHODS
Cell lines and reagents
The murine EEC line STC-1 (Mark Babayatsky, The Mount Sinai Medical School, New
York, NY) was maintained in DMEM with 4.5 g/l glucose and L-glutamine supplemented
with 10% FBS (Gemini) and 1% penicillin-streptomycin (Cellgro) and kept in a humidified
incubator at 37°C and 5% CO2. Human embryonic kidney (HEK)-293T cells and human
intestinal epithelial Caco-2 cells were grown in subconfluent monolayers in DMEM with 4.5
g/l glucose and L-glutamine supplemented with 10% FBS. Recombinant transforming
growth factor (TGF)-β1 was purchased from R&D Systems. The synthetic BLP (sBLP)
Pam3Cys-SKKKK was purchased from EMC Microcollections (Tuebingen, Germany). LPS
from Salmonella enteritidis was purchased from Sigma and was repurified to eliminate
TLR2-contaminating ligands by modified phenol extraction as previously described (16).
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Multimerized NF-κB DNA binding element luciferase reporter was obtained from Dr.
Adrian Ting (The Mount Sinai School of Medicine, New York, NY). A heat shock protein
(HSP) promoter-β-galactosidase reporter plasmid was used to normalize for transfection
efficiency as previously reported (56). A constitutively active CD4-TLR4 fusion protein
plasmid was obtained from Ruslan Medzhitov (Yale University) (29).
Murine macrophages
Bone marrow (BM) from femurs of C57BL/6 mice were flushed with washing medium
(RPMI-1640 with 1% penicillin-streptomycin), passed through a 70-μm nylon cell strainer
into a 50-ml conical tube, and spun down at 1,500 rpm for 5 min. Red blood cells were lysed
using sterile-filtered 0.8% ammonium chloride, washed twice with washing medium, and
resuspended in complete medium (washing medium with 10% FBS). BM cells were seeded
in complete medium in a 150-mm dish and differentiated using recombinant murine
granulocyte-macrophage colony-stimulating factor (GM-CSF; 20 ng/ml, R&D Systems). At
day 3, another 25 ml of fresh culture medium containing GM-CSF were added to the culture
plates. At day 7, the cells, representing the BM-derived macrophage population, were
harvested. For peritoneal macrophages, 3 ml of 3% thioglycollate were injected
intraperitoneally into C57BL/6 mice. Five days later, mice were euthanized, and adherent
cells isolated from peritoneal exudate fluid were used in experiments.
Transient gene expression assays and cell activation
STC-1 cells were plated in six-well plates. Once cells were 50–80% confluent, they were
transiently transfected using Superfect (Qiagen) reagent following the manufacturer's
protocol. Cells were transfected with the reporter genes NF-κB-luciferase (0.6 μg) and HSP-
β-galactosidase (0.5 μg) in 1.1 ml. Following transfection, cells were activated with bacterial
ligands. Eight hours after activation, cells were lysed in reporter lysis buffer, and luciferase
activity was measured with a luciferase assay system (Promega) using Turner Designs
Luminometer TD20/20. Transfection efficiency was assessed by β-galactosidase activity in
the same cell lysates. The ratio of the two parameters (luciferase:β-galactosidase) was used
for data presentation as previously reported (56).
MAPK activation
Cells were stimulated for the times shown in Fig. 7. Cells were harvested and lysed as
described previously (54). Whole cell lysates were immunoblotted for phosphorylated
ERK1/2 MAPK and total ERK2 MAPK using specific polyclonal antibodies (Santa Cruz
Biotechnology).
Immunohistochemistry
Paraffin-embedded tissue sections of the histologically normal human colon and ileum
derived from surgical resections of patients with colon cancer were deparaffinized and
microwaved in antigen unmasking solution (Vector Laboratories) for 15 min. If cryosections
were used, slides were fixed in 10% formalin. Intestinal sections were procured from the
Department of Pathology, The Mount Sinai Medical Center, and had been deidentified of
any patient data as part of an Institutional Review Board-approved tissue bank. C57Bl/6
murine colonic sections were fixed in 2% paraformal dehyde and incubated overnight in
30% sucrose before being cryosectioned.
For diaminobenzidine (DAB) staining, slides were placed in 0.3% H2O2-methanol for 10
min to block endogenous peroxidase activity. Slides were preincubated with PBS containing
5% serum of the same allotype as the secondary antibody. Isotype-matched purified
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immunoglobulin or primary antibody was applied. Slides were washed in PBS and incubated
with a secondary antibody against the Fc fragment of the primary antibody. Depending on
the immunohistochemistry technique, secondary antibodies were labeled with a fluorescent
marker (Alexa488, Cy3, FITC, or Texas red), biotin, or alkaline phosphatase. After slide had
been incubated with biotin-labeled antibodies, horseradish peroxidase-streptavidin was
applied to the slides followed by DAB solution (ImmunoCruz Staining System, Santa Cruz
Biotechnology). If alkaline phosphatase-labeled antibody was used, slides were incubated
with levamisole solution (Vector Laboratories) to block human alkaline phosphatase, and
slides were stained using the Red Alkaline Phosphatase Substrate Kit I (Vector
Laboratories).
Antibody binding to antigen was neutralized by preabsorption with specific blocking
peptides. Anti-TLR1 and anti-TLR2 antibodies were preincubated with a fivefold excess of
corresponding blocking peptides (Santa Cruz Biotechnology) overnight at 4°C. Afterward,
the antibody-peptide solution was applied to the slides.
Nuclei were counterstained with Harris Modified Hematoxylin (Fisher) or with Hoescht
stain. Slides were dehydrated and mounted using Vectashield mounting medium with 4′,6-
diamidino-2-phenylindole (Vector Laboratories), gelvatol for fluorescent dyes, or Immu-
mount (Shandon, Pittsburgh, PA) for DAB and Texas red dyes.
Slides were visualized with a microscope configured for fluorescence imaging (Olympus
BX60 or Olympus Provis), fitted with a cooled charge-coupled device (CCD) color camera
and frame grabber (Optronix or Magnifier) or confocal laser scanning microscope (Leica
TCP-SP), and analyzed using Metamorph (Molecular Devices, Sunnyvale, CA).
Antibodies and their working concentrations
Anti-human TLR1, TLR1-biotinylated, TLR2, TLR4, and TLR6 antibodies (goat
polyclonal, Santa Cruz Biotechnology) were used at concentrations between 2 and 5 μg/ml;
anti-human TLR4 and anti-TLR4/MD2 antibodies (rabbit polyclonal, eBioscience) were
used at a concentration of 5 μg/ml. All anti-human TLR antibodies used (except TLR1) were
cross reactive against mouse TLRs. Anti-serotonin antibody (NCLSEROTp, rabbit
polyclonal, Novocastra, UK; or rabbit polyclonal, Calbiochem) was diluted 1:200 or 1:500,
respectively. Anti-multicytokeratin-4/5/6/8/10/13/18 antibody (NCL-C11, mouse
monoclonal, Novocastra) antibody was diluted 1:10. Biotinylated secondary antibodies were
obtained from Santa Cruz Biotechnology.
RT-PCR, nitrite determination, and ELISA
Cells were harvested by TRIzol (Invitrogen), and total RNA was isolated as per the
manufacturer's protocol. For TLR mRNA detection, RNA samples were treated by DNaseI
(Ambion). For reverse transcription, a SuperScript Preamplification System (Invitrogen) was
used. PCR amplification was performed with Taq polymerase (Promega). Primer design and
specific conditions are shown in Table 1. All sequences were designed based on cDNA
sequences obtained from the GenBank database. For ELISA, STC-1 supernatants were
removed and assayed for the presence of TNF (BD Pharmingen), macrophage inhibitory
protein (MIP)-2, and TGF-β (R&D Systems) following the manufacturer's protocol. The
stable nitric oxide (NO) metabolite nitrite was measured using Griess reagent as previously
described (53). Values were measured using a plate reader and SOFTMax Pro version 4.0
software (Molecular Devices).
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STC-1 cells were pretreated for 30 min in the presence or absence of 20 μM BAPTA-AM
(Calbiochem) and then stimulated for 10, 30, 60, or 180 min with media, LPS, sBLP, or
bombesin (BBS) (AnaSpec, San Jose, CA). Supernatants were centrifuged to remove
cellular debris and analyzed for CCK by enzyme immunoassay (EIA) following the
manufacturer's protocol (Phoenix Pharmaceutical, Belmont, CA).
Calcium imaging
STC-1 cells in six-well plates were loaded in Ca2+/Mg2+-free PBS (Invitrogen) containing
10% FBS and 5 μM fura2-AM (Molecular Probes) diluted from a 1 mM DMSO stock for
15–20 min at 37°C. After being loaded, cells were thoroughly rinsed with 10% FBS-PBS.
For fluorescence recording, we used a BX61WI Olympus Optical (Tokyo, Japan)
microscope, a CCD camera (Hamamatsu, Shizouka, Japan), and a Lambda-LS xenon arc
lamp light source (Sutter, Novato, CA). Cells were imaged at room temperature using
Compix imaging systems and SimplePCI software (Compix, Cranberry, PA) at excitation
wavelengths of 340/380 nm at a rate of 1 frame/3 s before and during the application of 1
μg/ml LPS.
Statistical analyses
Statistical significance was assessed by two-tailed Student's t-test. P values of ≤0.05 were
considered to be statistically significant.
RESULTS
Human crypt IECs coexpress TLR1, TLR2, and TLR4
Functional TLR2, TLR3, TLR4, and TLR5 gene products are expressed in IEC lines, but the
distribution of TLRs in primary human IECs is more controversial. Therefore, the
expression of TLR1–TLR5 was determined in the human intestinal epithelium by
immunohistochemistry using intestinal specimens derived from surgical resections. Specific
polyclonal antibodies to human TLR1, TLR2, TLR3, TLR4, and TLR5 were used in these
experiments. A crypt cell demonstrating strong immunoreactivity for the combination of
TLR1 (Fig. 1, A–C), TLR2 (Figs. 1, A and C, and 2), and TLR4 (Fig. 1B) was identified in
the uninflamed ileum (n = 5 of 5 specimens; Supplemental Fig. 1C) and colon (n = 9 of 9
specimens; Figs. 1–3).1 TLR-expressing cells were almost exclusively located in the crypts
(2–5 cells/crypt). Colocalization of TLR1 with TLR2 (Fig. 1, A and C) and TLR1 with
TLR4 (Fig. 1B) immunoreactivity were demonstrated by fluorescent double labeling. No
immunoreactivity was observed with an antibody to TLR3 or TLR5 in IECs or in the lamina
propria (data not shown). TLR1-, TLR2-, and TLR4-stained IECs were observed in
experiments performed on paraffin-embedded sections (Figs. 1 and 2) following antigen
recovery and on frozen sections (Supplemental Fig. 1D). Immunoreactivity for TLR1,
TLR2, and TLR4 was specific, as staining was not detected with species- and isotype-
matched control primary antibodies (Supplemental Fig. 1, A and B), and identical
immunostaining patterns were demonstrated using fluorescent (Figs. 1–3) and alkaline
phosphatase (Supplemental Fig. 1, C and D)-labeled secondary antibodies. Moreover, to
confirm specificity of immunostaining, different secondary antibodies were used for TLR
detection [TLR1: anti-goat FITC (Fig. 1A) and TLR1-biotin, streptavidin-phycoerythrin
(PE) (Fig. 1B); TLR2: anti-goat FITC (Fig. 1A) and anti-goat PE (Fig. 2)]. Importantly,
TLR1 (Supplemental Fig. 1A) and TLR2 (Supplemental Fig. 1B) immunoreactivity were
1Supplemental data for this article is available online at the American Journal of Physiology-Gastrointestinal and Liver Physiology
website.
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abrogated by preincubating the respective antibody with specific blocking peptides. As final
specificity controls, antibodies for TLR1, TLR2, and TLR4 detected their respective human
receptor expressed in transfected HEK-293T cells by immunohistochemistry, but did not
cross react with other TLR family members (Supplemental Fig. 2). Furthermore, specific
human antibodies detected transfected TLR2 and endogenous TLR1 of the expected size by
Western immunoblot/coimmunoprecipitation in HEK-293T cells and immunoprecipitated
endogenous TLR4 in the enteroendocrine IEC line BON (Supplemental Fig. 3).
In the lamina propria of intestinal tissue sections, TLR immunoreactivity of cells
morphologically consistent with macrophages was present. However, the intensity of
staining was much lower than the crypt epithelial cells (Figs. 1 and 2 and Supplemental Fig.
1). No other cells in the epithelium appearred to stain with anti-TLR1, anti-TLF2, anti-
TLF3, anti-TLF4, and anti-TLF5 antibodies, but this finding does not exclude the possibility
of low-level TLR expression and immunoreactivity of other IEC populations (Figs. 1 and 2
and Supplemental Figs. 1 and 2).
TLR expression in IECs colocalizes with the enteroendocrine marker serotonin
To further morphologically characterize IECs that express TLRs, costaining experiments
were performed with TLR antibodies and a monoclonal antibody to an epithelial cell
marker, multicytokeratin. Colocalization of TLR2 immunoreactivity with NCL-C11
confirmred that these cells were, in fact, IECs (Fig. 2). IECs expressing TLRs are
morphologically different from conventional absorptive epithelial, goblet, and Paneth cells.
They have features reminiscent of the enteroendocrine lineage, including a pyramidal shape
with a large basolateral surface, an apically displaced nucleus, and a granular appearance.
To determine whether the IECs immunoreactive for TLR1, TLR2, and TLR4 were EECs,
immunohistochemistry was performed with a polyclonal antibody to serotonin. Serotonin
expression was detected in uninflamed human ileal and colonic sections, and serotonin
immunoreactivity colocalized with TLR1 staining (Fig. 3A) and TLR2 (Fig. 3B). Identical
immunostaining patterns were observed in murine colonic sections using anti-TLR
antibodies cross reactive to murine TLR2 (Fig. 4A), TLR6 (Fig. 4B), and TLR4 (data not
shown) that colocalize with serotonin immunoreactivity. Thus, an IEC that expresses a
combination of TLRs represents a highly differentiated population and belongs to the
enteroendocrine lineage. The characterization and distribution of these TLR-expressing
epithelial cells suggest that they represent a novel population of IECs with a potential role in
innate immune responses in the intestinal mucosa.
EEC lines express TLRs
To begin to determine functional consequences of TLR expression by EECs, the presence of
TLRs in intestine-derived EEC lines was determined. The murine EEC line STC-1 (38)
expresses mRNA transcripts for TLR1, TLR2, TLR4, TLR6, and the TLR4 coreceptor MD2
(Fig. 5A). The RAW264.7 murine macrophage cell line was used as a positive control for
TLR expression. Compared with RAW264.7 cells, STC-1 cells expressed qualitatively
lower levels of TLR mRNA. Furthermore, STC-1 cells expressed TLR2 (Fig. 5C), the
TLR4/MD2 complex (Fig. 5D), and TLR6 (Fig. 5E) protein. Thus, the STC-1 EEC line
expresses the same repertoire of TLRs observed in primary human and murine EECs.
TLR ligands activate NF-κB and MAPK pathways in STC-1 cells
Activation of the NF-κB family of transcription factors is a central downstream signaling
event in TLR-mediated cellular activation and regulates gene expression in many cell types.
To determine whether TLR expression on EECs is functional, STC-1 cells were transiently
transfected with a NF-κB luciferase reporter plasmid and stimulated with the TLR4 ligand
LPS or the TLR1/TLR2 ligand sBLP. STC-1 cells demonstrated a dose-dependent
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transcriptional activation of the NF-κB reporter to TLR ligands (Fig. 6). The activation of
MAPK is another important signaling event in TLR-mediated responses. Accordingly,
STC-1 cells were stimulated with LPS or sBLP to assess MAPK activation. Phosphorylation
of ERK1/2 MAPK was detected as early as 2 min (Fig. 7). These experimental results
support the presence of an intact intracellular signal transduction pathway downstream of
TLRs, leading to NF-κB and MAPK activation in EECs.
TLR ligands induce cytokine and chemokine expression in STC-1 cells
Absorptive enterocytes participate in innate immune responses through the elaboration of
cytokines such as TNF and chemokines like IL-8 when activated by pathogenic bacteria
through TLRs. Whether EECs are programmed for similar responses is unknown. STC-1
cells were stimulated with LPS or sBLP. MIP-2 (the murine homologue of human IL-8) and
TNF expression was evaluated by RT-PCR (Fig. 8A). TLR ligands induced rapid
accumulation of MIP-2 mRNA, which was detected after 2 h with maximal expression after
4 h of stimulation. Kinetics for TNF mRNA induction showed maximal levels between 2
and 4 h and slowly returned to baseline levels at the end of 8 h for each TLR ligand (data not
shown). Likewise, LPS and sBLP induced concentration dependent secretion of MIP-2 (Fig.
8, B and C) and TNF (Fig. 8, D and E) protein that remain elevated after 96 h (data not
shown).
LPS induces TGF-β in STC-1 cells
IECs also secrete factors that inhibit immune responses and may serve to maintain mucosal
homeostasis in vivo. TGF-β is a regulatory cytokine constitutively expressed in freshly
isolated IECs, with increased mRNA expression detected toward the base of the crypts (22).
The relevant source among primary IECs remains to be determined, although TGF-β protein
is produced in both the small intestine and colon (25). TGF-β is involved in oral tolerance
(47), inhibits T and B cell proliferation, and antagonizes macrophage activation (24). In
unstimulated STC-1 cells, basal expression of TGF-β mRNA was detected (Fig. 9A). Upon
stimulation with LPS, maximal expression was induced at 4 h. Supernatants were also
analyzed for TGF-β protein over 72 h. An increase in the spontaneous secretion of TGF-β in
unstimulated samples was observed from 24 to 72 h. Additionally, a dose-dependent
increase of TGF-β protein over the baseline amounts was detected in LPS-activated STC-1
cells (Fig. 9B). To further support a role for TLR activation in TGF-β expression, STC-1
cells were transfected with a constitutively active TLR4 expression plasmid (29), which
induced TGF-β secretion in an LPS-independent, concentration-dependent manner (Fig.
9C). Expression of pro- and anti-inflammatory molecules by an EEC line suggests that
TLRs expressed on EECs may contribute to innate immune responses and mucosal
homeostasis.
LPS induces calcium flux in STC-1 cells
One of the identifying characteristics of EECs is the presence of preformed storage vesicles
that contain numerous bioactive compounds with hormonal and neurotransmitter properties.
Calcium fluxes are associated with fusion events of storage vesicles (3, 48) and have been
previously described in EECs stimulated with fatty acids (15, 52). To determine whether
bacterial ligands caused calcium fluxes, STC-1 cells were loaded with fura-2 and challenged
with LPS or vehicle (PBS) (Fig. 10). After the introduction of LPS, there was an increase in
the 340-to-380-nm ratio, indicating an increase in intracellular calcium. Levels retruned
toward resting baseline but remained elevated out to 10 min. When PBS vehicle was added,
no perturbation in the 360-to-380-nm ratio was detected. As controls, RAW264.7
macrophages and Caco-2 cells, which express functional TLR4, did not demonstrate calcium
flux (data not shown) in the presence of LPS. We speculate that increased intracellular
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calcium following TLR ligation leads to degranulation of EEC vesicles, suggesting a
specialized function for TLR signaling in this cell type.
LPS induces rapid secretion of CCK from STC-1 cells
We next addressed whether TLR activation may induce degranulation of EEC vesicles and
secretion of neurohormones. STC-1 cells were stimulated with LPS, sBLP, and BBS as a
positive control, and supernatants assayed for CCK (Fig. 11). LPS, but not sBLP, induced a
similar percent increase in CCK secretion as BBS, with slightly earlier kinetics (maximal
increase in release at 30 min compared with 60 min for BBS; Fig. 11A, open bars).
Furthermore, LPS- and BBS-stimulated CCK release is dependent on calcium, as
preincubation with the calcium chelator BAPTA-AM significantly reduced CCK release
(Fig. 11, A and C, filled bars).
STC-1 conditioned media inhibits LPS-activated macrophages
Neurohormones produced by EECs and other cells, such as somatostatin and CCK, have
been demonstrated to inhibit immune responses. (1, 7, 8, 12, 31). Resident lamina propria
macrophages are notably deficient in the expression of innate immune receptors and,
therefore, do not produce proinflammatory cytokines when stimulated by bacterial ligands
(44). Therefore, we explored the possibility that EECs may be involved in the
downregulation of innate immune responses in macrophages. Conditioned media obtained
from 4-day STC-1 cultures were transferred onto RAW264.7 cells, which were then
stimulated with LPS for 24 h. EEC supernatants inhibited NO production in LPS-stimulated
RAW264.7 cells (Fig. 12A). This inhibitory activity was concentration dependent, as
incremental inhibition of NO was demonstrated with 20–100% conditioned media (data not
shown). In contrast, 4-day conditioned media from the IEC line Caco-2 and HEK-293T cells
did not inhibit NO production in LPS-activated RAW264.7 cells. Cell viability was assayed
by trypan blue exclusion, which was ≥90% in each condition. Furthermore, STC-1
conditioned media inhibited NO production and IL-12 p40 protein expression in LPS-
activated murine peritoneal (Fig. 12, B and C) and BM-derived macrophages (Fig. 12, D and
E). To begin to determine the components of STC-1 conditioned media that may have
immunoinhibitory properties, experiments with candidate molecules were performed. The
EEC products serotonin, somatostatin, and CCK did not inhibit LPS-induced IL-12 p40 or
NO in murine BM-derived or peritoneal macrophages (data not shown). However, TGF-β
inhibited LPS-activated NO (Fig. 13A) and IL-12 p40 (Fig. 13B) production in murine
macrophages, suggesting that this growth factor, in part, mediates the inhibition of
macrophage activation.
DISCUSSION
In this study, we showed that a subset of human and murine IECs coexpresses TLRs and
belongs to the enteroendocrine lineage. Using an EEC line model, a broad range of
functional effects of TLR activation was demonstrated, including NF-κB and MAPK
activation, calcium fluxes and CCK secretion, and pro- and anti-inflammatory gene
expression. Taken together, this study proposes a novel role for EECs as participants in
mucosal innate immune responses and raises the hypothesis that EEC-bacterial interactions
help to maintain intestinal immune homeostasis.
Previous immunohistochemical analyses of TLR expression in the human intestinal mucosa
revealed different interpretations from our study (2, 5, 6, 13, 14, 30, 32, 35, 49). These
seemingly discrepant results may have several explanations. First, different antibodies were
used in these studies. The use of different antibodies may have resulted in qualitatively
different, but not necessarily mutually exclusive, staining patterns. We performed numerous
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controls to demonstrate the specificity of our immunohistochemical analysis. Second, our
staining for TLR2 and TLR4 may have been more sensitive, enabling the detection of
TLR2- and TLR4-expressing IECs that were not noted in the previous studies. Another
report (34) first described the immunohistochemical expression of TLR4 on a murine IEC
line and on the isolated murine intestinal crypt epithelium. In this well-controlled analysis,
staining of the crypt appeared to be diffuse, suggesting that cells of the enteroendocrine
lineage as well as other IEC types in the mouse may express TLR4 (19). Our study does not
exclude the possibility that TLRs are expressed on other IEC types in lower quantities.
Furthermore, this analysis was limited to the first five members of the TLR family. It is
certainly possible that EECs and other IECs express other TLR family members.
In the present study, a specific crypt epithelial cell morphologically different from
conventional absorptive epithelium coexpressed TLRs and was identified as a serotonin-
positive EEC (Figs. 1–3). EECs represent <1% of terminally differentiated cells in the
intestinal mucosa. The intestinal epithelium harbors at least 15 types of EECs that have been
characterized based on morphological criteria, the nature of their principal secretory product,
specific marker molecules, and their ability to express certain transgenes (39, 40, 43).
Serotonin-expressing cells represent the largest population, can be detected throughout the
whole intestine, and can be located in the crypt as well as along the villus (17, 41, 43).
Therefore, TLR-expressing IECs likely represent a distinct subpopulation of EECs.
Immune function associated with EECs is largely unknown. However, bacterial interactions
with EECs have been described: for example, cholera toxin (a secretory enterotoxin
produced by Vibrio cholerae) evokes intestinal fluid secretion via binding to its receptor
GM1 ganglioside on EECs, followed by serotonin release and activation of the enteric
nervous system (10, 50). Furthermore, the EEC product CCK has been described to be
elevated in an acute upper gastrointestinal infection with Giardia and prevents bacterial
translocation (23, 51). There have been few reports directly implicating the EEC in immune
responses. One study (55) described a close proximity between EECs and T lymphocytes in
the nonhuman primate gut mucosa, indirectly suggesting a functional interaction.
Additionally, colitis-prone T cell receptor-α-deficient mice were demonstrated to have a
decrease in the number of colonic EECs compared with age- and strain-matched controls
(42), suggesting that EECs may possess homeostatic functions. Perhaps the most intriguing
observation suggesting a role for bacterial interactions with EECs in human disease is the
description of increased EEC cells following acute bacillary enteritis and in postdysenteric
IBS (36, 45, 46).
EECs are activated by nervous stimulation and discharge their secretions into the blood
flowing through the villus capillary bed. This allows for stored peptides and secreted
proteins to appear immediately at the tissue-blood interface, where it may exert an effect on
leukocyte and monocyte recruitment. If this is the case, it suggests a role for EECs as highly
specialized “lifeguards” of the intestinal mucosa with the capacity for early recognition of
bacterial invasion with consequent recruitment of protective mechanisms mediated by the
enteric immune and nervous systems. Here, we report that TLR activation in an EEC line
was associated with a rapid calcium flux. It has been shown that exocytosis of secretory
granules requires membrane fusion, a calcium-dependent process (3, 48). We further
showed that CCK, an EEC product, was released in response to TLR signaling, perhaps
through activation of the MAPK signaling pathway (33). Although mobilization of
intracellular calcium is not a well-described downstream event of TLR activation,
degranulation of secre-tory products in response to TLR signaling has been previously
described in mast cells (26). We speculate that this may be a specific adaptation of EECs
with consequent release of enteric neurohormones from secretory vesicles in response to
TLR activation.
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Various neuropeptides expressed and released by EECs have been shown to inhibit immune
responses. For example, somatostatin inhibits bacteria-induced IL-8 in IECs (7), and CCK
inhibits LPS-mediated responses (8, 31). To date, we have not identified all of the potential
bioactive components that inhibit macrophage activation in STC-1 conditioned media. In
preliminary analyses, we have tested several described EEC products to determine whether
they may mediate this inhibitory activity. Incubation of RAW264.7 cells and BM-derived
macrophages with serotonin, somatostatin, or CCK did not inhibit NO or IL-12 p40
expression. We were interested in the observation that TGF-β is upregulated in LPS-
activated STC-1 cells given its well-described immunoregulatory functions (24, 47) and its
role in wound healing (4). TGF-β inhibited NO in BM-derived macrophages and IL-12 p40
expression in peritoneal macrophages (Fig. 13). Therefore, TGF-β may partially mediate the
inhibitory effect of STC-1 conditioned media.
A pivotal report further examined the importance of TLRs in the intestines. Mice deficient in
TLR2, TLR4, or the signaling molecule MyD88 demonstrated increased severity of dextran
sodium sulfate (DSS)-induced colitis and decreased survival compared with control mice
(37), demonstrating that engagement of TLRs through recognition of ligands on commensal
bacteria plays a beneficial role in intestinal homeostasis. This study is consistent with
hypotheses raised by our findings: EECs express TLRs and actively produce factors, such as
TGF-β, which may contribute to intestinal homeostasis and protection from epithelial
damage. Constitutive expression of TLRs suggests that EECs may actively recognize
bacteria even under normal physiological circumstances and contribute to the normal
immunosuppressive state in the intestine.
Another possible consequence of TLR ligation in EECs is the production of the neutrophil
attractant human IL-8 or murine MIP-2, used in our study as a readout in an EEC line model
system. The intestinal epithelium, through the production of chemotactic factors, initiates
the recruitment of immune cells to the lamina propria at sites of infection. Consequently,
reduced numbers of neutrophils were observed in the lamina propria of TLR4- and MyD88-
deficient mice treated with DSS (11).
That TLR-expressing IECs belong to the enteroendocrine lineage raises intriguing
hypotheses about how bacterial interactions regulate physiological and pathological
inflammation. Multiple effects of TLR activation were demonstrated in a murine EEC line,
but another caveat to this study is that there may be functional differences in TLR activation
between mice and humans. However, the striking similarity in immunostaining patterns in
EECs observed between species may suggest a conserved functional role. To fully
understand the functional consequences of TLR expression on EECs will necessitate much
more investigation, combining cell line and descriptive data with mouse models of mucosal
immunity and inflammation.
Supplementary Material
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Toll-like receptor (TLR)1, TLR2, and TLR4 were coexpressed by a human intestinal
epithelial cell (IEC) that mainly resides in the crypts. Paraffin-embedded tissue sections of
the histologically normal human colon and ileum were immunostained with specific
antibodies as described in detail in MATERIALS AND METHODS (A–C). A: double-immunofluorescent
staining of the colon with anti-TLR1 (FITC) and anti-TLR2 (Texas red) antibodies.
Asterisks show TLR1+TLR2+ cells in the epithelial monolayer. B: double-
immunofluorescent staining of the colon with anti-TLR4 (FITC) and anti-TLR1 (Texas red)
antibodies. Asterisks show TLR1+TLR4+ cells in the epithelial monolayer. Magnification:
×400. Scale bars = 50 μm. C: double staining of the colon with anti-TLR1 (Texas red; left)
and anti-TLR2 (FITC; right) antibodies and a superimposed image of both (middle). A
single epithelial cell located in a crypt was visualized by confocal microscopy.
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TLR2+ cells in the epithelial monolayer of the human colon express IEC-specific
cytokeratins. Double staining of the colon with IEC-specific anti-multicytokeratin (FITC)
and anti-TLR2 (Texas red) antibodies is shown. The asterisk shows a
TLR2+multicytokeratin+ cell in the intestinal crypt. Magnification: ×400. Scale bar = 50 μm.
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TLR-immunoreactive cells in human colonic specimens express an enteroendocrine cell
(EEC) marker, serotonin. A: double staining of the colon with anti-serotonin (FITC) and
anti-TLR1 (Texas red) antibodies. The asterisk shows a TLR1+serotonin+ cell in the
intestinal crypt. Magnification: ×400. Scale bar = 50 μm. B: double staining of the colon
with anti-serotonin (FITC) and anti-TLR2 (Texas red) antibodies. Asterisks show
TLR2+serotonin+ cells in the intestinal crypt. Magnification: ×400. Scale bar = 50 μm. IECs
expressing TLRs have features reminiscent of an EEC lineage, including a pyramidal shape
with a large basolateral surface, an apically displaced nucleus, and a granular appearance.
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TLR-immunoreactive cells in murine colonic specimens express an EEC marker, serotonin.
A and B: double staining of murine colonic sections with anti-TLR2 (Alexa488 secondary;
A) and anti-serotonin (Cy3 secondary; B), an EEC marker. C: superimposed image of A and
B with nuclei depicted in white and actin in blue. D and E: double staining of murine colonic
sections with anti-TLR6 (Alexa488 secondary; D) and anti-serotonin (Cy3 secondary; E). F:
superimposed image of D and E with nuclei depicted in white and actin in blue.
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The murine EEC line STC-1 expresses TLRs. A, top: expressions of TLR and MD2 mRNA
were analyzed by PCR of reverse-transcribed total RNA isolated from STC-1 cells. RNA
isolated from RAW264.7 macrophage cells was used as a positive control. RT-PCR
amplified β-actin mRNA is shown as a loading control (bottom). B–E: STC-1 cells were
stained (FITC secondary) with control IgG (B), anti-TLR2 (C), anti-TLR4/MD2 complex
(D), and anti-TLR6 antibodies (E). Experiments were repeated 3 times, and a representative
result is displayed.
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TLR1/2 [synthetic bacterial lipoprotein (sBLP)] and TLR4 (LPS) ligands activate NF-κB in
the murine STC-1 EEC line. NF-κB activation was assessed by transient transfection of a
plasmid with a multimerized NF-κB DNA binding element luciferase reporter. A and B:
STC-1 cells were stimulated for 8 h with a dose titration of sBLP (A) or LPS (B). Results are
expressed as relative light units normalized to β-galactosidase activity from a cotransfected
heat shock protein (HSP) promoter-β-galactosidase plasmid to correct for transfection
efficiency. The fold induction of NF-κB luciferase was compared with values in
unstimulated cells (equal to 1) for each group. Each result represents the mean ± SD of 3–5
experiments. *P < 0.05 and **P < 0.005 compared with unstimulated cells for each group.
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sBLP and LPS activate the ERK MAPK pathway in STC-1 cells. MAPK activation was
assessed in cells stimulated with LPS or sBLP (10 μg/ml) for 0, 2, 5, 10, or 30 min. Whole
cell extracts were isolated as described in MATERIALS AND METHODS. Western blots were probed for
phosphorylated (p)ERK1/2 and total ERK2 to determine equal loading. Experiments were
repeated 3 times, and a representative result is displayed.
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TLR ligands induce TNF and macrophage inhibitory protein (MIP)-2 mRNA and protein
expression in STC-1 cells. STC-1 cells were stimulated with 10 μg/ml of LPS or sBLP for
0–4 h. A: cells were harvested via TRIzol. Total RNA was isolated, digested with DNase I,
and subsequently reverse transcribed into cDNA. TNF, MIP-2, and β-actin PCR primer
sequences are described in MATERIALS AND METHODS. Experiments were repeated 3 times, and a
representative result is displayed. B–E: STC-1 cells were stimulated with increasing
amounts of LPS (B and D) or sBLP (C and E) for 48 h. ELISA was performed on cell-free
supernatants for MIP-2 (B and C) and TNF (D and E). Experiments were performed in
triplicate, and results represent means ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001
compared with unstimulated cells for each group.
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LPS and TLR4 induce transforming growth factor (TGF)-β expression in STC-1 cells. A:
STC-1 cells were grown in 1% FBS and stimulated with 10 μg/ml LPS for 0–6 h. Total
RNA was isolated and reverse transcribed. TGF-β and β-actin primer sequences are
described in MATERIALS AND METHODS. Experiments were repeated 3 times, and a representative
result is displayed. B: STC-1 cells were stimulated with 0.1–10 μg/ml LPS for 24, 48, or 72
h. ELISA was performed on the supernatants for TGF-β according to the manufacturer's
protocols. Experiments were performed in triplicate, and results represent means ± SD. *P <
0.05 compared with unstimulated cells for each time group. C: constitutively active (ca)-
TLR4 expression plasmid increased TGF-β production in transfected STC-1 cells. STC-1
cells were grown in 1% FBS and transfected with a total of 1 μg plasmid DNA (empty
vector pcDNA3 + ca-TLR4). STC-1 cells were incubated for 48, 72, or 96 h. ELISA was
performed on the supernatants for TGF-β according to the manufacturer's protocols.
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Experiments were performed in triplicate, and results represent means ± SD. *P < 0.05
compared with empty vector control for each time group.
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LPS induces a rapid calcium flux in STC-1 cells. STC-1 cells were loaded with fura-2 and
incubated in DMEM with 10% FBS. A and B: cells were initially stabilized. C and D: cells
were subsequently treated with 1 μg/ml LPS (addition of LPS), causing an increase in the
internal calcium concentration. Experiments were performed in trip-licate, and a
representative result is shown.
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LPS induces secretion of CCK in STC-1 cells. Cells were pretreated in the presence or
absence of the calcium chelator BAPTA-AM (20 μM) 30 min prior to being stimulated for
10, 30, 60, and 180 min with 1 μg/ml LPS (A), 10 μg/ml sBLP (B), or 10 nM bombesin
(BBS; C). Enzyme immunoassay was performed on cell-free supernatants for CCK.
Experiments were performed 4 times. Due to the variation of the baseline production of
CCK, results were normalized to controls (unstimulated) and presented as percentages of
control values. The average (mean + SD) baseline production of CCK was 1.8 ± 0.6 ng/ml.
Maximal stimulated CCK expression was 2.0 + 0.5 ng/ml for LPS, 1.8 + 0.6 ng/ml for
sBLP, and 2.1 + 0.8 for BBS; n = 4 experiments for each condition. *P < 0.05.
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STC-1 conditioned media (cm) inhibits LPS-stimulated IL-12 p40 and nitric oxide (NO)
production in macrophages. A–E: 4-day conditioned media from STC-1 cells were added to
RAW264.7 cells (A), murine peritoneal macrophages (B and C), or murine bone marrow
(BM)-derived macrophages (D and E). A: 4-day conditioned media from the IEC line
Caco-2 and epithelial cell line HEK-293T were used as controls. Macrophages were
subsequently stimulated with 1 μg/ml LPS for 24 h (A, B, and D) or 48 h (C and E).
Experiments were performed in trip-licate, and results represent means ± SD. **P < 0.01
compared with media control for each group.
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TGF-β inhibits LPS-stimulated IL-12 p40 and NO production in macrophages. BM-derived
(A) or peritoneal (B) macrophages were incubated with or without 5 ng/ml recombinant
human (rh)TGF-β1 prior to being stimulated with 1 μg/ml LPS. Supernatants were assayed
for NO (A) and IL-12 p40 (B). Experiments were performed in triplicate, and results
represent means ± SD. *P < 0.05 and ***P < 0.001 compared with media control for each
group.
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